New therapies for alcohol problems: application to primary care. Review uri icon

Overview

MeSH

  • Alcohol Deterrents
  • Alcohol Drinking
  • Clinical Trials as Topic
  • Humans
  • Naltrexone
  • Narcotic Antagonists
  • Psychotherapy
  • Research Design
  • Taurine
  • United States

MeSH Major

  • Alcohol-Related Disorders
  • Primary Health Care

abstract

  • Primary care physicians are frequently involved in the longitudinal care of patients with alcohol problems and in helping patients to decrease their alcohol consumption. Recent clinical trials provide evidence in support of new treatment strategies for these patients. Brief interventions have been used successfully to reduce alcohol consumption in patients with hazardous and harmful drinking. Twelve-step facilitation, cognitive behavioral, and motivational enhancement therapies have produced sustained drinking reductions in patients with alcohol dependence. Pharmacologic therapies, such as naltrexone and acamprosate, have been effective in decreasing alcohol consumption when provided along with psychosocial counseling in patients with alcohol dependence. The current review highlights the application of these new therapies to primary care physicians' efforts on behalf of their patients with alcohol problems.

publication date

  • February 15, 2000

has subject area

  • Alcohol Deterrents
  • Alcohol Drinking
  • Alcohol-Related Disorders
  • Clinical Trials as Topic
  • Humans
  • Naltrexone
  • Narcotic Antagonists
  • Primary Health Care
  • Psychotherapy
  • Research Design
  • Taurine
  • United States

Research

keywords

  • Journal Article
  • Review

Identity

Language

  • eng

PubMed ID

  • 10723977

Additional Document Info

start page

  • 227

end page

  • 237

volume

  • 108

number

  • 3